Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI

NCT00539240 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

236

Enrollment

FED

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Rabeprazole 20mg, placebo dinner and bedtime
DRUG: Rabeprazole 20 mg two times, Placebo at bedtime
DRUG: Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant

Sponsor

US Department of Veterans Affairs